Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the
pricing of an underwritten public offering of senior unsecured
notes consisting of $750,000,000 aggregate principal amount of
8.125% notes due 2029.
The sale of the notes is expected to close on August 12, 2024,
subject to customary closing conditions. WBA intends to use the net
proceeds from the offering, together with cash on hand, for the
repayment and/or retirement of its outstanding 3.800% notes due
2024, and to use any remaining amounts for general corporate
purposes.
The joint book-running managers for the offering are: J.P.
Morgan Securities LLC, Wells Fargo Securities, LLC and BofA
Securities, Inc.
This press release shall not constitute an offer to sell, or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of any such
jurisdiction.
These securities are being offered pursuant to an effective
shelf registration statement previously filed with the Securities
and Exchange Commission (“SEC”). The offering may be made only by
means of a prospectus and related prospectus supplement, copies of
which may be obtained on the SEC website at http://www.sec.gov or
by contacting J.P. Morgan Securities LLC, c/o Broadridge Solutions,
1155 Long Island Avenue, Edgewood, New York 11717, or call collect
at (866) 803-9204, Wells Fargo Securities, LLC, 90 S 7th, 5th
Floor, Minneapolis, Minnesota 55402, or call at +1-800-645-3751
(option #5) and BofA Securities, Inc. NC1-022-02-25, 201 North
Tryon Street, Charlotte, North Carolina, 28255-0001, Attn:
Prospectus Department, or call at 1-800-294-1322.
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated
healthcare, pharmacy and retail leader serving millions of
customers and patients every day, with a 170-year heritage of
caring for communities.
A trusted, global innovator in retail pharmacy with
approximately 12,500 locations across the U.S., Europe and Latin
America, WBA plays a critical role in the healthcare ecosystem. The
Company is reimagining local healthcare and well-being for all as
part of its purpose – to create more joyful lives through better
health. Through dispensing medicines, improving access to a wide
range of health services, providing high quality health and beauty
products and offering anytime, anywhere convenience across its
digital platforms, WBA is shaping the future of healthcare.
WBA employs more than 330,000 people and has a presence in eight
countries through its portfolio of consumer brands: Walgreens,
Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico.
Additionally, WBA has a portfolio of healthcare-focused investments
located in several countries, including China and the U.S.
The Company is proud of its contributions to healthy
communities, a healthy planet, an inclusive workplace and a
sustainable marketplace. WBA has been recognized for its commitment
to being an inclusive workplace. In fiscal 2023, the Company
received a score of 100 from the Human Rights Campaign’s Corporate
Equality Index, scored 100 percent on the Disability Equality Index
for disability inclusion and was named Disability:IN’s 2023
Employer of the Year. In addition, WBA has been recognized for its
commitment to operating sustainably as the company is an index
component of the Dow Jones Sustainability Indices (DJSI).
Cautionary Note Regarding Forward Looking Statements
All statements in this press release that are not historical are
forward-looking statements for purposes of the safe harbor
provisions of the Private Securities Litigation Reform Act of
1995.
These forward-looking statements are based on current
expectations, estimates, forecasts and projections about our future
performance, our business, our beliefs and our management's
assumptions. Some of these forward-looking statements may be based
on certain data and forecasts relating to our business and industry
that we have obtained from internal surveys, market research,
publicly availably information and industry publications. Industry
publications, surveys and market research generally state that the
information they provide has been obtained from sources believed to
be reliable, but that the accuracy and completeness of such
information is not guaranteed. These forward-looking statements
include all statements other than statements of historical facts
contained or incorporated by reference herein and therein,
including statements regarding the Company's future operations,
financial or operating results, capital allocation, anticipated
debt levels and ratios, future earnings, planned activities,
anticipated growth, goodwill impairment, market opportunities,
strategies, competition, and other expectations and targets for
future periods. Words such as “expect,” “outlook,” “forecast,”
“would,” “could,” “should,” “can,” “will,” “project,” “intend,”
“plan,” “goal,” “opportunity,” “guidance,” “projection,” “target,”
“aim,” “continue,” “transform,” “strive,” “enable,” “create,”
“position,” “accelerate,” “model,” “long-term,” “believe,” “seek,”
“estimate,” “anticipate,” “may,” “possible,” “assume,” “potential,”
“preliminary,” and variations of such words and similar expressions
are intended to identify such forward-looking statements.
These forward-looking statements are not guarantees of future
performance and are subject to risks, uncertainties and
assumptions, known or unknown, that could cause actual results to
vary materially from those indicated or anticipated. These risks,
assumptions and uncertainties include, but are not limited to,
those described in sections entitled “Item 1A. Risk Factors” in our
most recent Annual Report on Form 10-K and our Quarterly Reports on
Form 10-Q for the quarters ended February 29, 2024 and May 31, 2024
and in other documents that we file with the SEC. If one or more of
these risks or uncertainties materializes, or if underlying
assumptions prove incorrect, actual results may vary materially
from those indicated or anticipated by such forward-looking
statements. All forward looking statements we make or that are made
on our behalf are qualified by these cautionary statements.
Accordingly, you should not place undue reliance on these
forward-looking statements, which speak only as of the date they
are made.
We do not undertake, and expressly disclaim, any duty or
obligation to update publicly any forward-looking statement after
the date of this press release, whether as a result of new
information, future events, changes in assumptions or
otherwise.
(WBA-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240808129212/en/
WBA Media Relations USA / Jonathon Hosea, +1 224
507 9379 International, +44 (0)20 7980 8585
WBA Investor Relations Tiffany Kanaga, +1 847 315
2922
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Oct 2023 to Oct 2024